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Proper regulation of cytosolic Ca2þ is critical for pancreatic acinar cell function. Disruptions in normal Ca2þ concentrations affect numerous
cellular functions and are associated with pancreatitis. Membrane pumps and channels regulate cytosolic Ca2þ homeostasis by promoting
rapid Ca2þ movement. Determining how expression of Ca2þ modulators is regulated and the cellular alterations that occur upon changes in
expression can provide insight into initiating events of pancreatitis. The goal of this study was to delineate the gene structure and regulation of
a novel pancreas-speciﬁc isoform for Secretory Pathway Ca2þ ATPase 2 (termed SPCA2C), which is encoded from the Atp2c2 gene. Using
Next Generation Sequencing of RNA (RNA-seq), chromatin immunoprecipitation for epigenetic modiﬁcations and promoter-reporter
assays, a novel transcriptional start site was identiﬁed that promotes expression of a transcript containing the last four exons of the Atp2c2
gene (Atp2c2c). This region was enriched for epigenetic marks and pancreatic transcription factors that promote gene activation. Promoter
activity for regions upstream of the ATG codon in Atp2c2’s 24th exon was observed in vitro but not in in vivo. Translation from this ATG
encodes a protein aligned with the carboxy terminal of SPCA2. Functional analysis in HEK 293A cells indicates a unique role for SPCA2C in
increasing cytosolic Ca2þ. RNA analysis indicates that the decreased Atp2c2c expression observed early in experimental pancreatitis reﬂects a
global molecular response of acinar cells to reduce cytosolic Ca2þ levels. Combined, these results suggest SPCA2C affects Ca2þ homeostasis
in pancreatic acinar cells in a unique fashion relative to other Ca2þ ATPases.
J. Cell. Physiol. 231: 2768–2778, 2016. ß 2016 Wiley Periodicals, Inc.

Pancreatic acinar cells are polarized with highly organized
intracellular compartments that permit rapid receptorregulated exocytosis of enzymes. The precise spatial and
temporal control of Ca2þ release is fundamental for proper
exocytosis of enzymes (Lee et al., 1997). The ability for Ca2þ to
act as a second messenger in enzyme release is provided by the
maintenance of a cytosolic Ca2þ gradient with greater
concentrations of Ca2þ outside the cell or within intracellular
compartments such as the ER, relative to the cytosol. Transient
increases in cytosolic Ca2þ are coupled to exocytosis of
zymogen granules (ZG) containing enzymes (Burnham and
Williams, 1984), while dysregulation of intracellular Ca2þ
concentration affects gene transcription, cell proliferation,
apoptosis, or necrosis and is associated with the initiation of
pancreatitis (Zhou et al., 1996; Kruger et al., 2000; Li et al.,
2014).
The ability to restore the cytosolic Ca2þ gradient after ER
release is due, in part, to P-type Ca2þ ATPases that remove
Ca2þ from the cytosol (Lee et al., 1997). There are three
families of P-type Ca2þ ATPases. Sarcoendoplasmic reticulum
Ca2þATPases (SERCAs; encoded by three Atp2a genes)
translocate Ca2þ into the ER (Zhao et al., 2001; Arredouani
et al., 2002; Beauvois et al., 2004). Plasma membrane Ca2þ
ATPases (PMCAs; encoded by four Atp2b genes) translocate
Ca2þ out of the cell. The third type of Ca2þ ATPase is the
secretory pathway Ca2þ ATPases (SPCAs, encoded by two
Atp2c genes), which translocate Ca2þ into the Golgi (reviewed
in Vanoevelen et al., 2007; He and Hu, 2012). SPCA1/Atp2c1 is a
homolog of Pmr1/PMR1 ﬁrst described in Saccharomyces
cervisiae (Rudolph et al., 1989). SPCA1 is ubiquitously
© 2 0 1 6 W I L E Y P E R I O D I C A L S , I N C .

expressed and targeted deletion of Atp2c1 in mice results in
gestational growth retardation and death before embryonic
day 10.5 (Okunade et al., 2007). In humans, mutations in the
ATP2C1 are found in Hailey–Hailey disease (Sudbrak et al.,
2000). A second isoform, SPCA2/Atp2c2 is expressed only in
higher organisms (mammals) and is limited to a few tissues,
including secretory and absorptive epithelia of the
gastrointestinal, genitourinary, mammary, and salivary glands
(Vanoevelen et al., 2005). Unlike SPCA1, SPCA2 appears to
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have a broader localization pattern in the cell, found in the
Golgi, ER, and secretory vesicles (Xiang et al., 2005; Feng et al.,
2010; Garside et al., 2010; Pestov et al., 2012).
SPCA2 is found only in higher functioning organisms;
however, its deﬁnitive function is yet to be determined. In
lactating gland luminal epithelial, SPCA2 is localized
predominantly to vesicles that travel to the plasma membrane
rather than the Golgi and has a major role in increasing
intracellular Ca2þ (Cross et al., 2013). Human breast
adenocarcinoma MCF7 cells have higher SPCA2 expression
compared to MCF-10A, a non-malignant human mammary
epithelial cell line. Increased SPCA2 expression was also
observed in a small group of breast cancer patients suggesting a
potential link between SPCA2, cytosolic Ca2þ, and metastasis
(Feng et al., 2010). These studies also suggest that truncations of
SPCA2 may be involved in Store Independent Ca2þ Entry (SICE)
by activating ORAI1 protein function (Feng and Rao, 2013).
SPCA2 is translated from the Atp2c2 gene that spans a region
of 95.5 kb on human chromosome 16, which contains 27 exons.
SPCA2 is 946 amino acids long (Vanoevelen et al., 2005).
SPCA2 is expressed in pancreatic acinar cells, but
characterization of SPCA2 expression indicated a signiﬁcantly
smaller protein (Garside et al., 2010) than the predicted full
length SPCA2 (Vanoevelen et al., 2005; Pestov et al., 2012).
Expression analysis of this smaller SPCA2 isoform suggested a
novel function from the full length SPCA2 as it was localized to
both the Golgi and ER. Relevant to acinar cell physiology,
SPCA2 expression was markedly decreased in Mist1/ mice,
which show defects in Ca2þ handling (Garside et al., 2010). This
study also suggests that MIST1 may directly regulate pancreatic
expression of Atp2c2. While it is clear that the pancreatic
isoform, termed SPCA2C, contains at least the carboxy
terminus of SPCA2, without knowledge of the exact
transcriptional start site and exon/intron structure; it is unclear
what functional signiﬁcance SPCA2C has in Ca2þ homeostasis.
To appropriately study the function and regulation of SPCA2/
Atp2c2 in the pancreas, it is imperative to determine if Atp2c2c
is the result of altered splicing or a pancreatic-speciﬁc
transcriptional start site (TSS).
The goals of this study were to determine the complete
Atp2c2 transcript encoding SPCA2C, delineate factors
regulating Atp2c2 expression in the pancreas, and determine if
SPCA2C affects Ca2þ homeostasis. Our results show that
Atp2c2 is transcribed from a unique TSS in pancreatic acinar
tissue, encoding only the carboxy terminal portion of SPCA2.
In addition, over expressing SPCA2C is accompanied by
persistent elevation in cytosolic Ca2þ, revealing a novel role for
SPCA2C in regulating acinar cell function.
Materials and Methods
Mouse handling and initiation of cerulein-induced
pancreatitis
C57Bl/6 mice were used for all experiments except for transgene
analysis. Mice were handled according to guidelines approved by
the Animal Care and Use Subcommittee at the University of
Western Ontario (Protocols 2008-116 and 2008-027). Transgenic
mice carrying the 1181 þ 57Atp2c2 promoter region upstream
of a LacZ reporter gene were generated through pronuclear
injection of CBA/C57BL/6 hybrid zygotes followed by implantation
into CD1 pseudopregnant mice. Founder mice (F0) were mated to
C57Bl/6 mice, and 3–4-week-old F1 mice characterized for
transgene expression. 2–4-month-old male C57Bl/6 animals were
used for gene, ChIP, and RNA-seq analysis. The targeted deletion
of the Mist1 gene has previously been described (Pin et al., 2001).
Cerulein-induced pancreatitis (CIP) was initiated as described
(Kowalik et al., 2007) with 4–8 hourly intraperitoneal injections of
50 mg/kg cerulein (cholecystokinin analog) and mice sacriﬁced 4, 8,
32, and 72 h after initial injection.
JOURNAL OF CELLULAR PHYSIOLOGY

RNA isolation, qRT-PCR, and RNA-Seq
RNA was isolated from mouse pancreatic tissue using 50 Prime
isol-RNA Lysis Reagent (Fisher Scientiﬁc, Burlington, ON)
followed by PureLink RNA Mini Kit (Life Technologies, Waltham,
MA). RNA-seq was performed by The Centre for Applied
Genomics at The Hospital for Sick Children (Toronto, ON). The
full details of the RNA-seq will be provided elsewhere (Fazio et al.,
unpublished; GEO accession number to follow).
ChIP-PCR, chIP-seq, and bioinformatics analysis
Chromatin was isolated from pancreatic tissue of C57/Bl6 mice
or Mist1/ pancreatic tissue mice as described (Johnson et al.,
2014; Mehmood et al., 2014). Chromatin immunoprecipitation
(ChIP) was performed using antibodies speciﬁc for MIST1
(Johnson et al., 2004), Histone 3 lysine 36 trimethylation
(H3K36Me3; Abcam, Cambridge, MA), RNA polymerase II
(Millipore, Temecula, CA), H3K4Me3, and H3K27Me3 as
described (Mehmood et al., 2014). ChIP was followed by qPCR
using the GoTaq PCR Mastermix system (Promega, Madison,
WI). Samples were evaluated using the ABI Prism 7900HT
Sequence Detection System and Vii A7 RUO software (Applied
Biosystems, Foster City, CA). Average Ct values for individual
ChIP and IgG controls were expressed as a percent of starting
chromatin samples (input). Alternatively, H3K4Me3 ChIP was
followed by Next Generation sequencing (ChIP-Seq; the
complete dataset is described (Mehmood et al., 2014).
Plasmid construction
Putative promoter regions upstream of the ATG codon in exon 24
of the Atp2c2 gene (Supplementary Fig. S1), which corresponds to
þ2,580 (RNA sequence) or þ54,891 (DNA sequence) in the full
length Atp2c2 sequence were designed based on the UCSC
Genome browser identiﬁcation of Atp2c2 (uc009nqg.1) and
constructed by Invitrogen GeneArt (Regensburg, Germany). The
Atp2c2-Luciferase2 sequence was cloned into pGL3Basic using Xho1
and HindIII cloning sites and veriﬁed by Sanger sequencing. The ﬁnal
promoter-reporter constructs were designated in relationship to
the ﬁrst base pair based on ChIP-seq data and include
1181 þ 57Atp2c2cpGL3, 562 þ 57Atp2c2cpGL3, and
252 þ 57Atp2c2cpGL3 (Supplementary Fig. S1). A similar
approach was used to generate a 1238 bp region upstream of the
ATG codon found in exon 23 (Alt-ATG-Atp2c2pGL3). Promoterless pGL3 and pWHERE plasmids were used as negative controls
for all transfection assays.
To generate a transgene promoter construct,
1181 þ 57Atp2c2cpGL3 was digested with XhoI and SmaI and
cloned into pWHERE (Invitrogen, San Diego, CA) digested with the
same enzymes. Finally, a pcDNA3.1 expression vector containing
the exact SPCA2C reading frame was generated by GeneArt using
sequence information from NCBI (Accession #AC_000030.1).
The Atp2c2c sequence was followed by the FLAG antigenic tag
sequence (50 GATTACAAGGATGACGACGATAAG 30 ;
pcDNA-SPCA2FLAG) and then a stop codon.
Cell culture and luciferase assays
Human embryonic kidney (HEK) 293A cells were maintained in
Dulbecco’s Modiﬁed Eagle Medium (DMEM) high glucose media
(HyClone, Logan, UT) containing 10% FBS and 1% Penstrep. When
cultures reached 70–80% conﬂuence, cells were transfected using
JetPrime transfection kit, with Atp2c2c promoter-luciferase or
promoter-LacZ plasmids described above. Promoter-less pGL3
and pWHERE plasmids were used as controls. Forty-eight hours
after transfection, protein was isolated using the Dual-Luciferase
Reporter Assay Kit (Promega). Luciferase analysis was performed
in triplicate using the Lumat LB 9507 Luminometer (Berthold
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Technologies, Oakridge, TN). Fireﬂy luciferase amounts were
normalized to Renilla luciferase values, and this ratio normalized to
expression of pGL3-Basic. Data was analyzed using GraphPad Prism
software version 6.0 by two way analysis of variance (ANOVA)
with a Bonferroni post hoc test. Graphs show mean
values  standard error of measure (SEM).
Calcium imaging
HEK293 cells were transfected as described above with
pcDNA3.0GFP, pcDNA3.1-SPCA2CFLAG, or pcDNA3.1-SPCA2MYC
(encodes full length SPCA2; kindly provided by R. Rao; (Feng et al.,
2010). Forty-eight hours after transfection cells were loaded with
Fura-2 AM at 1 mM in culture media (Dulbecco’s Modiﬁed Eagle
Medium (DMEM) high glucose media (HyClone) containing 10% FBS
and 1% Penstrep) for 30 min at 37°C and 5% CO2. After loading,
cells were rinsed once in Hank’s Buffered Saline Solution (HBSS;
140 mM NaCl, 4.7 mM KCl, 1.13 mM MgCl, 10 mM glucose, 10 mM
HEPES, 1.8 mM CaCl) and then allowed to rest for 10 min at room
temperature in HBSS before recording started. Cells were excited
at 340 nm and 380 nm, and Fura2 emissions at 505 nm were
measured per individual cell. Changes in the Fura-2 ﬂuorescence
ratio using excitation wavelengths of 340/380 nm were taken as a
measure of changes in intracellular Ca2þ levels while individual
groups of cells were stimulated with 10 mM carbachol for 5 min at a
pressure of 2 Pa by pufﬁng. Five-minute pufﬁng experiments
were completed no more then three times per plate, and never on
the same group of cells. N values are provided for each study within
the ﬁgure legends. Data is shown þ/ SEM and signiﬁcance was
determined using a one way ANOVA and Tukey’s posthoc test.
Immunoﬂuorescence analysis
HEK293 cells were transfected as described above with
pcDNA3.1-SPCA2CFLAG and/or pcDNA3.1-SPCA2MYC. Forty-eight
hours after transfection, HEK293 cells were ﬁxed with 4%
formaldehyde in PBS. IF was performed as described (Garside et al.,
2010). A mouse antibody for FLAG (diluted 1:500, Sigma) or rabbit
antibody speciﬁc for MYC (1:1000, Sigma), were diluted in blocking
solution (PBS, 5% BSA, 1% triton). Fluorescently labelled secondary
goat antibodies were diluted 1:250 in PBS (Jackson Immunoresearch
Labs, West Grove, PA or Sigma, Oakville, ON, Canada). We
acquired confocal images using a Leica SP5 Confocal microscope and
the colocalization ﬁnder plugin for ImageJ (http://1.usa.gov/1Pn0ru1)
was used to determine overlap of ﬂuorochromes.
Results

The pancreatic isoform of Atp2c2/SPCA2 is signiﬁcantly smaller
(Garside et al., 2010) than the published full-length molecule
that has been reported in the literature (Vanoevelen et al.,
2005). However, it is unclear whether the pancreas transcript
(termed Atp2c2c; c for carboxy) was the result of an alternative
transcriptional start site (TSS) or alternative splicing of the
larger Atp2c2 transcript. To resolve this question, the Atp2c2
genomic region was visualized with the USCS Genome
browser using RNA-seq data on total pancreatic tissue from 2month-old mice (Fig. 1A). Examination of the complete Atp2c2
gene showed no sequence enrichment in exons 1–23,
indicating that these exons were not transcribed within the
pancreatic genome. Sequence alignment was observed 41 bp
into exon 24 (Fig. 1B), corresponding to þ2403 in the fulllength transcript, and included all of the remaining exons
(24–27) of the Atp2c2 gene (Supplemental Fig. S3). Examination
of other Atp2 genes showed no unique splicing variants but a
potential alternative TSS for Atp2b1 (Supplementary Fig. S2A).
Examination of RNA-seq data from other regions of the
gastrointestinal tract (GEO accession number: GSE36025)
showed some enrichment along the entire Atp2c2 gene with
JOURNAL OF CELLULAR PHYSIOLOGY

greater sequence enrichment of exons near the 30 end of the
Atp2c2 gene (Supplementary Fig. S4), suggesting that other
tissues may contain unique isoforms for Atp2c2 as well as
heterogeneity in the Atp2c2 isoform expressed. However,
none of these tissues express only the pancreatic isoform we
have identiﬁed.
Several Expressed Sequence Tags (ESTs) have been
identiﬁed for Atp2c2, but only EST AK00749.1, previously
identiﬁed in a 10-day-old pancreatic EST library, showed
alignment to Atp2c2c (Fig. 1A and B). Interestingly, alignment
of the AK00749.1 sequence with the full length Atp2c2
identiﬁes a single missing G nucleotide, which is not missing in
our RNA-seq data, indicating that Atp2c2c perfectly aligns with
the last 702 bp of Atp2c2.
Based on the RNA-seq and AK00749.1 sequences, we
designated the ﬁrst bp of the Atp2c2c transcript as þ41 bp into
exon 24 of the Atp2c2 gene. Examination of the Atp2c2c
sequence identiﬁed an open reading frame that initiates from an
ATG codon at þ57 into Atp2c2c and produces a protein that
perfectly aligns with the last 136 amino acids of SPCA2
(designated SPCA2C; Fig. 2A; Supplementary Fig. S3). SPCA2C
contains the last four transmembrane domains, part of the
cation ATPase domain and a cation binding site found within
SPCA2 (Supplementary Fig. S3B).
The region upstream of the Atp2c2c TSS was examined for
putative transcription factor binding motifs using the AlibabaGene Regulation Data Base and Nsite—softberry (http://www.
softberry.com). Several binding motifs were identiﬁed including
NFkB-TNFa-K.3 (NF-kB), Sp1-Ku80 (Sp1), and NF-IL6-CCR1
(NF-IL6) consensus sites (data not shown). However, no
consensus TATA box sequence was observed within this
region. Therefore, to conﬁrm that the 23rd intron and initial
part of the 24th exon of the Atp2c2 gene drive expression of
Atp2c2c, we took two approaches. First, this region of Atp2c2
was characterized for the enrichment of epigenetic marks
consistent with TSSs (Fig. 2). Trimethylation of Histone 3 lysine
4 (H3K4Me3) typically occurs at primed or active TSSs
(Ruthenburg et al., 2007). Examination of previously published
ChIP-seq data for H3K4Me3 enrichment (Mehmood et al.,
2014) in pancreatic acinar cells identiﬁed signiﬁcant enrichment
at exon 24, but not at any other part of the Atp2c2 gene, even
the TSS for the full length transcript (Fig. 2A). We conﬁrmed
speciﬁc enrichment for H3K4Me3 at exon 24 using targeted
ChIP-qPCR along the Atp2c2 gene (Fig. 2B and C). Since
H3K4Me3 can also mark distal enhancer regions (Pekowska
et al., 2011), ChIP-qPCR was performed for epigenetic marks
that occur near TSSs, including H3 acetylation (H3Ac),
H3K36Me3, and RNApol II. In each case, increased enrichment
was observed around exon 24 of the Atp2c2 gene (Fig. 2D),
supporting this region as a novel TSS.
As a second approach to demonstrate promoter activity of
this region in the Atp2c2 gene, regions extending 1238 bp
(1181 þ 57pGL3), 619 bp (562 þ 57pGL3), and 309 bp
(252 þ 57pGL3) from the starting ATG codon within Atp2c2
exon 24 were placed in front of a luciferase reporter gene
(Fig. 3A). As a control, a separate 1238 bp sequence upstream
of an ATG codon within exon 23 (Alt-ATG-Atp2c2pGL3) was
tested. Transient transfection into HEK 293A cells revealed
signiﬁcantly increased activity for 1181 þ 57pGL3,
562 þ 57pGL3, and 252 þ 57pGL3 compared to the pGL3
vector alone (Fig. 3B). The Alt-Atp2c2pGL3 construct showed
no such activity (Fig. 3B). Similar promoter activity was
observed when the 1181 þ 57 sequence region was placed
upstream of a nuclear LacZ cassette (1181 þ 57pWHERE).
Distinct b-galactosidase expression was observed upon
transfection in HEK 293A (Fig. 3C) again conﬁrming promoter
activity. To determine if the 1181 þ 57pWHERE promoterreporter construct was active in vivo, we generated several
transgenic lines through pronuclear injection (Fig. 3D). In total,

A NOVEL ROLE FOR SPCA2C IN THE PANCREAS

Fig. 1. Transcription from the Atp2c2 gene is limited to the last four exons within pancreatic tissue. A: RNA-seq visualization of the Atp2c2
gene reveals sequence enrichment only with exons 24 to 27. The only EST that corresponds with this sequence is AK007419 (arrow). B:
Higher resolution of the RNA-seq data indicates that Atp2c2c starts within the 4th exon, exactly where the AK007419 EST begins (downward
arrow). However, Atp2c2c contains the single G nucleotide missing within the published sequence for AK007419 (open arrow). C: The Atp2c2c
sequence produces an open reading frame that generates a 136 aa protein that aligns with the carboxy terminus of SPCA2.

nine founder lines were identiﬁed containing
1181 þ 57pWHERE. Evaluation of pancreatic tissue using
whole mount b galactosidase analysis revealed no detectable
expression above control levels (data not shown). In an
attempt to identify more limited expression, we performed
RT-PCR analysis for LacZ mRNA (Fig. 3E). No detectable LacZ
JOURNAL OF CELLULAR PHYSIOLOGY

expression could be discerned. These ﬁndings suggest that the
1181 bp promoter region for Atp2c2c does not contain all of
the regulatory elements required for pancreatic-speciﬁc
expression.
Atp2c2c expression is signiﬁcantly reduced in mice lacking
the transcription factor MIST1 (Mist1/; Garside et al., 2010),
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Fig. 2. Enrichment for epigenetic histone modifications and transcription factors are observed at exon 24 within the Atp2c2 gene. A:
Alignment of RNA-Seq of whole pancreatic RNA to the Atp2c2 gene in wild type (WT) mice was compared to ChIP-seq for H3K4Me3
(K4Me3) enrichment in WT pancreatic tissue. B: Schematic showing the regions of the Atp2c2 gene amplified by targeted ChIP-qPCR. A–E:
represent the putative amplicons generated by ChIP-PCR. ChIP-qPCR for (C) H3K4Me3 or (D) H3 acetylation (H3Ac), H3K36Me3, and RNA
polymerase II (PolII) reveals increased enrichment around exon 24. In all cases, n ¼ 3.

which is a model of increased pancreatitis susceptibility with
deﬁcits in Ca2þ homeostasis (Kowalik et al., 2007). Supporting
the existence of the 24th exon of Atp2c2 containing a TSS,
ChIP-seq for H3K4Me3 in pancreatic tissue from Mist1/ mice
revealed a marked loss in enrichment, consistent with
decreased expression (Fig. 4A). ChIP-PCR and ChIP-qPCR also
showed enrichment for MIST1 near the TSS in exon 24
(Fig. 4B and C) suggesting it directly regulates Atp2c2c
expression.
Based on this decrease in expression in Mist1/ mice, we
predicted that Atp2c2c expression may also be altered in
response to cerulein-induced pancreatitis (CIP). Cerulein is a
CCK analogue that at pharmacological levels initiates a
pancreatitis response that involves premature enzyme
activation, altered cell signalling, and initiation of
inﬂammatory genes (Williams et al., 2002). RNA-seq showed
a rapid decrease in Atp2c2c expression 4 h after initiating CIP
(Fig. 4D and E), which was conﬁrmed by qRT-PCR (Fig. 4F).
Atp2c2c expression remained low in CIP treated mice
relative to saline-treated mice even as long as 72 h after initial
injection. Interestingly, Atp2c2c expression showed a
markedly different response compared to the genes
encoding other Ca2þ ATPases (Fig. 4G; Supplementary
Fig. S2B; and Table 1). All other Atp2 genes showed either no
difference or increased expression 4 h into CIP treatment.
The increased gene expression for several Ca2þ ATPase
isoforms suggests that acinar cells may upregulate genes
that promote a decrease in cytosolic Ca2þ. Analysis of the
RNA-seq data for genes affecting Ca2þ 4 h into CIP identiﬁed
JOURNAL OF CELLULAR PHYSIOLOGY

expression of 193 out of a possible 254 genes (76%) linked to
Ca2þ regulation in either saline or cerulein-treated tissue
based on Gene Ontology categorization. Twenty-six genes
(10.3% of all known-related Ca2þ genes or 13.5% of those
Ca2þ genes expressed in the pancreas) are signiﬁcantly upregulated in that time, with an additional 21 genes (8.3% or
10.9%, respectively) down-regulated. Therefore, >24% of all
genes expressed in the pancreas that affect Ca2þ levels are
altered within 4 h of initiating CIP). Using Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway,
these genes were mapped to pathways affecting cytosolic
Ca2þ (Supplementary Fig. S5). The effects of altered
expression were predicted for each gene that would affect
cytosolic Ca2þ based on the published protein function
(Table 1). A distinct trend was observed in which genes
encoding proteins that elevate cytosolic Ca2þ, such as
CCKAR and IP3R3, were signiﬁcantly reduced. Conversely,
several Ca2þ ATPase encoding genes, including Atp2a2 and
Atp2b2, were signiﬁcantly increased. Atp2c2c fell within the
former group suggesting that it may promote increased
cytosolic Ca2þ.
To test this theory, HEK293 cells were transfected with
GFPþ/ plasmids encoding a full length myc-tagged SPCA2
(SPCA2MYC), or a FLAG-tagged C-terminal truncated protein
that completely mimicked the coding region of SPCA2C
(pcDNA3.1-SPCA2CFLAG). Examination of protein localization by
co-IF analysis for SPCA2CFLAG and SPCA2MYC showed
overlapping localization of the two proteins (Fig. 5). However,
there were also regions of unique accumulation, indicating
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Fig. 3. The genomic region upstream of the Atp2c2c transcript exhibits promoter activity. A: Schematic of promoter-reporter constructs
containing 1238 bp (1181 þ 57Atp2c2cpGL3), 619 bp (562 þ 57Atp2c2cpGL3), and 309 bp (252 þ 57Atp2c2pGL3) of sequence upstream of the
Atp2c2c TSS. Note: these constructs contain the complete 50 UTR for Atp2c2c. B: Reporter activity following transfection of luciferase
reporter constructs into HEK293  P < 0.05. Values are normalized to luciferase activity in the pGL3 vector that does not contain any promoter
fragment. C: LacZ histochemistry of HEK293 cells transiently transfected with CMV-LacZ, pWHERE with no promoter, or pWHERE containing
the 1181 þ 57Atp2c2c region in front of LacZ. D: Representative PCR for transgene in genomic DNA from one litter of potential founder
mice identifying three positive samples. Control is genomic DNA spiked with the equivalent of 10 copies (10C) of the transgenic plasmid.
E: RT-PCR for LacZ RNA expression in founder mice, Mrpl was used as loading control and non-transgenic DNA spiked with 5 or 10 copies
(C) of 1181 þ 57Atp2c2cpWHERE plasmid.

different cellular localization of the full length and SPCA2C
isoforms. HEK293 cells expressing SPCA2CFLAG showed a
signiﬁcant increase in resting cytosolic Ca2þ relative to GFP or
SPCA2MYC-expressing cells using Fura2 ratiometric analysis
(Fig. 6A and B). In addition, expression of SPCA2CFLAG
JOURNAL OF CELLULAR PHYSIOLOGY

resulted in greater increases in cytosolic Ca2þ following
carbachol stimulation (Fig. 6A and C) while SPCA2MYC showed
only a trend towards signiﬁcance. These results suggest that
SPCA2C elevated basal cytosolic Ca2þ levels, opposite to the
functional role of other Ca2þ ATPases.
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Fig. 4. Atp2c2c expression is reduced during pancreatitis. A: Schematic showing of ChIP-seq for H3K4Me3 enrichment in WT and Mist1/
pancreatic tissue. B: ChIP-PCR and (C) ChIP-qPCR indicates MIST1 localizes to regions near exon 24 of the Atp2c2 gene. RNA-seq at low
(D) and high (E) resolution for Atp2c2c expression 4 h after initiating CIP. F: qRT-PCR confirms significantly reduced Atp2c2c expression until
at least 72 h into CIP. G: Visualization of Atp2 gene expression using the UCSC genome browser and RNA-seq tracks developed from whole
pancreatic RNA obtained 4 h into cerulein or saline treatment. Atp2c2c expression is significantly decreased by CIP treatment, while Atp2a2,
Atp2a3, Atp2b1, and Atp2c1 are all significantly reduced.

Discussion
2þ

The importance of Ca as a second messenger for pancreatic
acinar exocytosis and cell function is well established. Ca2þ
ATPases, including those of the PMCA and SERCA families,
have key roles in acinar cell biology (Lee et al., 1997; Prasad
et al., 2004). We have previously shown that SPCA2 is
JOURNAL OF CELLULAR PHYSIOLOGY

expressed to high levels in the pancreas (Garside et al., 2010),
but little is known about its function in this tissue. In this study,
we show that the novel pancreatic isoform of SPCA2
(SPCA2C) is transcribed from a novel TSS within the Atp2c2
gene that generates a transcript that includes only the last four
exons of the full length Atp2c2 gene. The SPCA2C protein
sequence aligns with the carboxy terminus of SPCA2.

A NOVEL ROLE FOR SPCA2C IN THE PANCREAS

TABLE 1. Expression of Ca2þ-regulating genes 4 hours after inducing CIP
Gene
Itpkc
Sphk1
Ncs1
Cacnb2
Trpc1
Micu3
Atp2a2
Calm2
Atp2b1
Atp2a3
Adora2b
Calm1
Plcg2
Adcy4
Adcy9
Ppp3r1
Plcd1
Chrm3
Cherp
Vdac3
Orai2
Mcu
P2rx1
Orai3
Itpr2
Itpka
Prkaca
Atp2c2
Ptger3
Grpr
Gna14
Chrm1
Cckar

log2 (fold change)

Effect on cytosolic Ca2þ

6.25602
5.01899
4.03756
2.68014
2.57667
1.91612
1.69111
1.67262
1.38563
1.23098
1.02344
0.999638
0.956653
0.902953
0.831247
0.78638
0.774936
0.750425
0.709924
0.68958
0.660906
0.738988
0.843921
1.01062
1.08852
1.09573
1.17005
2.1948
1.36579
2.20381
2.89861
3.03857
4.22087

Remove
—
Remove
Add
Add
Remove
Remove
—
Remove
Remove
—
—
Add
—
—
Remove
Add
Add
Add
Remove
Add
Remove
Add
Add
Add
—
—
?
Add
Add
Add
Add
Add

Referencea
Li et al. (2013)
Nakamura et al. (2011)
Breitenkamp et al. (2014)
Willoughby et al. (2014)
Plovanich et al. (2013)
Ringpfeil et al. (2001)
Strehler and Treiman (2004)
Bobe et al. (2004)
Streb et al. (1985)
Guerini (1997)
Jaken and Yuspa (1988); Punnonen et al. (1993)
Wess et al. (2007)
Laplante et al. (2000)
Huang et al. (2013)
Mercer et al. (2006)
Patron et al. (2013)
North (2002)
Mercer et al. (2006)
Yamamoto-Hino et al. (1994)

Morimoto et al. (2014)
Xiao et al. (2003)
Hubbard and Hepler (2006)
Wess et al. (2007)
Pandol et al. (1985)

a

Effect on cytosolic Ca2þ was determined based on function reported in literature.

Fig. 5. Intracellular protein accumulation of SPCA2MYC and SPCA2CFLAG. Co-localization of SPCA2CFLAG and SPCA2MYC following
transfection of HEK293A cells shows cellular regions that express either SPCA2CFLAG (green; closed arrow) or SPCA2MYC (red; open arrow),
or both (white). Images represent optical Z-axis slices that are separated by 3 mm. Magnification bar is 9 mm in all parts.
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Fig. 6. SPCA2C exhibits a unique Ca2þ signaling function. A:
Ratiometric Fura2 fluorescence analysis of single cell responses
following transfection of GFP or GFPþ SPCA2CFLAG. Lines indicate
the duration of 10 mm carbachol stimulation. B: Measurement of
resting cytosolic Ca2þ levels (before stimulation) or (C) the maximal
response to carbachol stimulation show increased cytosolic Ca2þ
levels and release only in cells transfected with SPCA2CFLAG. P and
N values are shown on the graphs. Cells transfected with the full
length SPCA2 show a trend towards increased maximal Ca2þ
release.

Importantly, SPCA2C shows decreased expression during CIP,
and is part of a larger molecular response by the acinar cells to
possibly reduce basal and stimulated cytosolic Ca2þ levels
following acute pancreatic injury.
Most of the Atp2 genes encode several isoforms of Ca2þ
ATPase proteins, giving rise to extensive cell-speciﬁc
expression patterns for these genes. In most cases, these
isoforms are the result of alternative splicing. In the case of
Atp2c2c, the alternative isoform expressed within the pancreas
is the result of a TSS that exists within the 24th exon of the
gene. Our previous reports of a pancreatic speciﬁc Atp2c2c
transcript suggested a size of 1.2 kb (Garside et al., 2010),
signiﬁcantly larger than the 702 bp transcript identiﬁed in this
study. This is likely due to the different methodologies used.
RNA-Seq analysis is signiﬁcantly more accurate than Northern
blot analysis, allowing the identiﬁcation of a TSS within a few
base pairs, and does not include the polyA tail that increases the
size of the mature transcript. The identiﬁcation of this TSS is
based on high resolution RNA-seq data, combined with
characterization of epigenetic modiﬁcations that are known to
exist speciﬁcally at TSSs. This includes enrichment of histone
marks such as H3K4Me3, H3K36Me3, and acetylated H3. Both
H3K36Me3 and H3 acetylation also extend along the gene
corresponding to transcription (Schwartz et al., 2009;
Gunderson et al., 2011), which was observed for the Atp2c2c
gene. At the same time, this region is enriched for RNA PolII
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based on targeted ChIP-PCR. Previous results indicate that
Mist1/ acini show negligible amounts of SPCA2C expression
suggesting MIST1 regulates Atp2c2c expression (Garside et al.,
2010). ChIP indicates that MIST1 directly binds in close
proximity to the TSS in exon 24, and the absence of MIST1
correlates with reduced H3K4Me3, an epigenetic mark
enriched at the TSS of active or primed genes (Ruthenburg
et al., 2007). These results suggest that MIST1 is an important
regulator of ATP2c2c transcription.
The 252 bp region upstream of the Atp2c2s TSS is sufﬁcient
to promote transcription, and the addition of an extra 900 bp
upstream of this region does not appear to increase promoter
efﬁcacy. Surprisingly, this region does not promote expression
in vivo suggesting additional promoter and enhancer regions
are required to recapitulate Atp2c2 expression in the pancreas.
Indeed, MIST1 enrichment appears to peak downstream of the
24th exon, and co-transfection of the Atp2c2c promoter
reporter constructs with MIST1 did not affect promoter
activity (data not shown). This suggests that the promoter
regions do not include regions where MIST1 binds. While
the 1181 þ 57 Atp2c2c region tested includes several putative
E boxes (binding sites for basic helix-loop-helix proteins), none
of these correspond to the preferred MIST1 binding site, and
analysis of the intronic region between exons 24 and 25
identiﬁed an E-box with the canonical CATATG (Tran et al.,
2007) sequence preferentially targeted by MIST1 (data not
shown).
Importantly, delineation of the complete transcript of
Atp2c2c identiﬁed an open reading frame (ORF) within the
transcript that encodes a 136 amino acid protein that perfectly
aligns with the carboxy terminus of the full length SPCA2,
hence the designation of SPCA2C. Previous work had shown
that the pancreas-speciﬁc isoform contain the C terminus of
the protein (Garside et al., 2010), but had not identiﬁed the
exact sequence of the protein. Sequence alignment conﬁrms
that SPCA2C completely lacks four transmembrane domains,
the E1–E2 hydrolase domain, a Ca2þ binding site, as well as
other domains common to P-type ATPases suggesting that
SPCA2C does not act as a Ca2þATPase in acinar cells. Nor is it
likely to act as a competitor for the full length SPCA2 since both
RNA-seq data and epigenetic analysis indicate non-detectable
amounts of this isoform in pancreatic tissue.
In other cell types, SPCA2 affects both Ca2þ accumulation
within the Golgi and store-independent Ca2þ entry (SICE;
Vanoevelen et al., 2005; Faddy et al., 2008; Feng and Rao, 2013),
and truncated versions of SPCA2 affect ORAI1 function in cell
lines (Cross et al., 2013), suggesting a Ca2þ signaling role for
SPCA2C. We have now conﬁrmed that SPCA2C has both a cell
localization pattern and affect on cytosolic Ca2þ, that is, unique
from the full length SPCA2 protein. Co-localization of epitopetagged SPCA2 and SPCA2C indicates that their localization is
not identical. Since RNA-seq suggests that SPCA2C is the only
isoform of Atp2c2 expressed in the pancreas (>99% of total
amount), the previous documentation of endogenous SPCA2
accumulation likely indicates only SPCA2C (Garside et al.,
2010). Previous studies have shown a direct interaction of
SPCA2 with ORAI channels, and the ability of C terminal
regions of SPCA2 to affect SICE (Feng and Rao, 2013).
This study also suggests a global molecular response in acinar
cells to reduce cytosolic Ca2þ levels. Genes encoding proteins
that normally increase cytosolic Ca2þ are decreased within 4 h
of inducing CIP. This includes decreases in Atp2c2c, which is
unlike the other Atp2 genes that either do not change
expression or increase during CIP. The decreased Atp2c2c
expression supports a function that is opposite to other Ca2þ
ATPases and is in line with a role for SPCA2C in increasing
cytosolic Ca2þ. As mentioned, SPCA2 interacts with ORAI1composed plasma membrane Ca2þ channels, promoting SICE
and Ca2þ inﬂux into the cytosol (Cross et al., 2013).

A NOVEL ROLE FOR SPCA2C IN THE PANCREAS

Importantly, the regulation of SICE by SPCA2 is mediated
through the carboxy terminus of SPCA2 (Feng and Rao, 2013).
Our ﬁndings support a role in which expression of SPCA2C
increases cytosolic Ca2þ and Ca2þ release following carbachol
treatment. Recent studies indicate that inhibition of ORAI1
channels during pancreatitis is protective (Voronina et al.,
2015), and reduced expression observed of Atp2c2c during CIP
may be protective via decreased ORAI1 activation. Ultimately,
a more complete analysis of SPCA2C function and how it
affects SICE and GPCR-mediated Ca2þ release is needed to
fully understand its role in pancreatic function. Targeted
knockouts of Atp2c2 have not been reported to date.
However, this study suggests that targeting the full length
Atpc2c2 gene will not uncover a pancreatic phenotype, since
using typical gene trapping strategies will leave the truncated
gene and alternate TSS intact. Therefore, our identiﬁcation of
the novel TSS will enable more appropriate strategies for
targeting Atp2c2.
In conclusion, this study determines that the truncated form
of Atp2c2 is transcribed from a novel TSS within the 24th exon
and produces a protein that retains the C-terminus of the fulllength protein. Transcription from this TSS appears to be
regulated in part by MIST1 and repressed during pancreatic
injury. Future studies are required to determine how SPCA2C
regulates acinar cell function and how this function relates to
the response of the acinar cell during pancreatic injury.
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